Intracellular drug delivery using poly(D,L-lactide-co-glycolide) nano-particles derivatized with a peptide from a transcriptional activator protein of HIV-1

Biotechnology Letters

Volumn 24, Issue 24, 2002, Pages 2093-2098

  Nam, Yoon Sung ^a   Park, Ju Young ^a   Han, Sang Hoon ^a   Chang, Ih Seop ^a  

^a AmorePacific Corporation   (South Korea)

Author keywords

Biodegradable polymer; Conjugates; Nanoparticles; Protein transduction domain (PTD); Tat peptide

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036955764     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021373731787     Document Type: Article

References (15)

1. Allen C, Maysinger D, Eisenberg A (1999) Nano-engineering block copolymer aggregates for drug delivery. Colloid. Surf. B. 16: 3-27.
2. Bayley H (1999) Protein therapy-delivery guaranteed. Nat. Biotech. 17: 1066-1067.
3. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
4. Cho CS, Jeong YI, Ishihara T, Takei R, Park JU, Park KH, Maruyama A, Akaike T (1997) Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 18: 323-326.
5. Dawson GF, Halbert GW (2000) The in vitro cell association of invasin coated polylactide-co-glycolide nanoparticles. Pharm. Res. 17: 1420-1425.
6. Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269: 10444-10450.
7. Düzgüne N, Nir S (1999) Mechanisms and kinetics of liposome-cell interactions. Adv. Drug. Del. Rev. 40: 3-18.
8. Lavasanifar A, Samuel J, Kwon GS (2002) The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). J. Control. Rel. 79: 165-172.
9. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55-63.
10. Müller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug. Del. Rev. 47: 3-19.
11. Nam YS, Park TG (1999) Protein loaded biodegradable microspheres based on PLGA-protein conjugates. J. Microencaps. 16: 625-637.
12. Schwartz JJ, Zhang S (2000) Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther 2: 162-167.
13. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572.
14. Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 10699-10704.
15. Zhang L, Eisenberg A (1995) Multiple morphologies of 'crew-cut' aggregates of polystyrene-b-poly(acrylic acid) block copolymers. Science 268: 1728-1731.